Now showing items 3-4 of 4

    • MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. 

      Block, Matthew S; Vierkant, Robert A; Rambau, Peter F; Winham, Stacey J; Wagner, Philipp; Traficante, Nadia; Tołoczko, Aleksandra et al. (Mayo Medical Ventures, 2018-03)
      Objective: To evaluate myeloid differentiation primary response gene eighty-eight (MyD88) and toll like receptor 4 (TLR4) expression in relation to clinical features of EOC, histologic subtypes and overall survival. Patients ...
    • PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS 

      Southey, Melissa C; Goldgar, David; Winqvist, Robert; Pylkäs, Katri; Couch, Fergus; Tischkowitz, Marc Derek; Foulkes, William et al. (BMJ Publishing Group, 2016-09-05)
      Background The rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate precisely associated cancer risks. Population-based family studies have provided evidence that at least some of these mutations are ...